Abbott Laboratories ABT Ratios (2009-2026)

NYSE ABT
$100.98 +0.00 (+0.00%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Abbott Laboratories Quarterly Ratios

Periods 69 quarters
Latest Jun 2026

Abbott Laboratories reported a gross margin of 57.71% and a net margin of 7.37% for the quarter ended Jun 2026. These financial ratios cover 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
59.53%58.44%58.07%56.18%55.53%54.48%55.57%55.07%54.60%55.51%55.21%55.64%55.83%54.97%56.86%56.44%55.36%57.05%56.20%57.71%
EBT Margin
22.81%20.29%24.18%20.89%16.89%13.08%16.03%16.40%16.47%17.53%14.41%15.49%18.24%18.50%17.17%19.30%19.17%20.58%12.98%12.10%
EBIT Margin
23.30%20.74%24.48%21.11%17.00%12.92%15.48%15.45%16.24%17.38%13.91%16.08%17.48%17.41%16.34%18.42%18.09%19.64%12.05%13.44%
EBITDA Margin
31.05%28.44%31.40%28.41%24.83%20.92%23.75%23.47%24.36%25.32%21.99%23.84%25.01%24.77%23.64%25.39%25.05%26.56%19.24%21.86%
Operating Margin
23.30%20.74%24.48%21.11%17.00%12.92%15.48%15.45%16.24%17.38%13.91%16.08%17.48%17.41%16.34%18.42%18.09%19.64%12.05%13.44%
Net Margin
19.14%17.27%20.50%17.93%13.78%10.24%13.52%13.78%14.16%15.56%12.29%12.55%15.48%84.10%12.79%15.97%14.46%15.50%9.65%7.37%
FCF Margin
20.50%21.39%14.66%18.04%22.22%17.01%7.83%6.98%12.98%22.29%6.29%13.75%20.21%19.57%9.01%13.87%20.15%22.92%8.20%15.81%
Efficiency
Inventory AverageInventory Avg.
5.35B5.21B5.42B5.79B5.82B5.95B6.42B6.77B6.76B6.61B6.70B6.82B6.81B6.50B6.42B6.80B6.83B6.60B6.74B7.15B
Assets AverageAssets Avg.
73.53B74.50B74.60B74.10B73.50B73.62B74.12B73.57B72.72B72.65B72.84B72.74B73.69B77.89B81.43B82.72B84.09B85.45B98.57B109.82B
Equity AverageEquity Avg.
34.33B35.33B35.83B36.17B36.30B36.39B37.07B37.32B37.55B38.26B38.94B39.30B39.79B43.96B48.48B49.95B51.05B52.02B52.74B52.23B
Invested CapitalInvested Cap.
53.03B54.07B52.72B53.48B52.30B53.68B54.13B54.25B53.22B53.51B53.63B54.31B55.01B62.03B62.31B64.27B64.20B65.70B86.75B84.37B
Asset Utilization RatioAsset Util.
0.580.580.600.610.610.590.560.550.550.550.550.560.560.540.520.520.520.520.460.42
Leverage & Solvency
Interest Coverage RatioInterest Cover
19.1418.1522.2318.0012.558.479.869.709.9211.199.8311.9213.0914.0512.9216.9617.0018.767.734.82
Debt Ratio
0.250.240.230.230.230.230.230.230.220.200.200.200.200.170.160.160.150.150.310.30
Times Interest Earned
19.1418.1522.2318.0012.558.479.869.709.9211.199.8311.9213.0914.0512.9216.9617.0018.767.734.82
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
2.612.482.932.441.741.261.481.541.621.801.281.351.719.631.291.731.591.720.980.84
FCF Payout RatioFCF Cover
0.360.330.480.410.360.481.171.280.670.391.530.670.450.451.100.670.450.391.200.55
Dividend YieldDiv. Yield
1.46%1.29%1.56%1.71%1.95%1.73%1.91%1.81%2.08%1.86%1.83%2.04%1.90%1.96%1.69%1.68%1.74%1.89%2.34%2.71%
Payout Ratio
0.420.450.420.380.420.480.580.660.680.620.640.660.650.290.290.280.290.630.670.79
Valuation
Price to EarningsP/E
28.9635.2426.9322.3121.4327.5630.3436.6632.5733.3735.1232.5334.2914.6417.0916.9316.6633.3728.4928.94
Price to SalesP/S
4.945.764.664.183.754.374.244.704.214.764.904.444.804.685.455.495.314.913.963.37
Price to BookP/B
6.036.895.825.184.705.174.735.064.464.925.064.574.944.104.704.664.544.133.393.03
Enterprise Value
199.41B237.35B199.31B181.21B159.01B180.86B166.78B181.26B161.30B183.94B191.31B173.82B190.19B188.44B224.20B229.70B225.48B209.42B172.18B152.06B
EV to EBIT
23.5228.1721.6017.7416.8521.6323.9729.5926.8728.3930.1026.8228.4127.6131.4430.5729.2326.0022.3520.70
EV to EBITDA
16.6219.8415.7513.3412.4415.5516.3419.3817.4618.9219.9317.8719.1818.7621.7621.5620.7918.7515.8414.09
Market Capitalization
208.89B248.19B207.24B190.27B168.71B190.81B176.09B189.19B168.14B190.99B197.73B180.79B197.75B196.17B230.79B236.72B232.90B217.71B178.83B157.01B
Price to FCFP/FCF
22.4328.7025.4222.4719.7524.4525.8134.4737.4337.7540.1631.9830.4930.8934.6734.9433.6729.4424.2420.07
EV to FCF
21.4127.4524.4521.4018.6223.1824.4433.0335.9136.3638.8630.7429.3229.6733.6833.9032.6028.3223.3419.44
EV to CFO
17.7022.5320.0117.6915.4018.8819.2624.3224.6325.3326.7822.0021.7922.0225.0525.4224.7321.8918.1915.35
Return Ratios
Return on Sales [ROS]ROS
23.30%20.74%24.48%21.11%17.00%12.92%15.48%15.45%16.24%17.38%13.91%16.08%17.48%17.41%16.34%18.42%18.09%19.64%12.05%13.44%
Return on Capital Employed [ROCE]ROCE
13.98%13.72%14.89%16.55%15.69%14.38%11.68%10.34%10.06%11.01%10.80%10.99%11.39%10.71%10.42%10.85%11.10%11.68%9.61%7.98%
Return on Invested Capital [ROIC]ROIC
14.06%13.55%14.76%16.37%15.11%13.17%10.72%9.29%9.32%10.43%10.22%10.25%10.42%11.66%11.47%11.87%12.01%9.55%7.80%6.20%
Return on Assets [ROA]ROA
9.85%9.49%10.36%11.54%10.73%9.42%7.83%7.01%7.10%7.88%7.73%7.64%7.83%17.21%16.58%16.90%16.62%7.64%6.37%4.94%
Return on Equity [ROE]ROE
21.10%20.01%21.56%23.65%21.73%19.05%15.66%13.83%13.75%14.96%14.46%14.14%14.49%30.48%27.85%27.99%27.38%12.54%11.90%10.39%

Abbott Laboratories Ratios API

Pull Abbott Laboratories's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ABT&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY